New Clinical Trials for High Cholesterol
High cholesterol is an important condition to diagnose, manage and treat, both on its own and as an indicator of other problems. If you have high cholesterol and have tried to treat it unsuccessfully with diet and exercise, or even with medication, we would like to talk to you. There is much more to learn and ongoing high cholesterol clinical studies are needed.
(For more information, please see: High Cholesterol Symptoms, High Cholesterol Drugs & Medication, and High Cholesterol Causes)
There are ongoing high cholesterol clinical trials that you can participate in if you qualify. Please review the list and contact us if you are interested in participating. As always there is no cost to you to participate in clinical trials.
What is High Cholesterol?
High cholesterol, also known as hypercholesterolemia, is a condition where there are high levels of cholesterol in the blood. High cholesterol can have many causes, but the main one is heart disease. It is closely related to hyperlipidemia that occurs when there are a high number of lipids found in the blood. Diet, genetics, diabetes, and an under-active thyroid are other potential causes for high cholesterol. The U.S. Preventative Services Task Force recommends screening for high cholesterol as an early indicator of heart disease. Cholesterol is made up of different types of fat – LDL, HDL and VLDL. It is important to measure each when determining harmful levels of cholesterol.
High Cholesterol Treatments
High cholesterol treatments include lifestyle changes. In obese people with high cholesterol that has been caused by their diet, the condition can sometimes be improved when they improve their diet. Quitting smoking and reducing the intake of alcohol can also be helpful. If lifestyle changes don’t work, then drugs may be prescribed. The American College of Physicians has set some guidelines for the treatment of high cholesterol. Treating high cholesterol may involve the use of statins and lipid lowering therapies.
We've found
1,593 High Cholesterol
clinical trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
A Study of Evacetrapib (LY2484595) in Participants With High Cholesterol
Status: Enrolling,
Phase
III
Updated: 12/23/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Gastroenterology, Pharmacology / Toxicology Clinical Trial
Novel Therapies for Metabolic Complications of Lipodystrophies
Status: Enrolling,
Phase
II, III
Updated: 6/19/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
Status: Enrolling,
Phase
I
Updated: 9/5/2014
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
Status: Enrolling,
Phase
I, II
Updated: 3/7/2011
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Calorie Restriction and Changes in Body Composition, Disease, Function, and Quality of Life in Older Adults
Status: Enrolling
Updated: 3/15/2013
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling,
Phase
II
Updated: 10/5/2015
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Evaluation of ARI-3037MO, to Suppress LDL Cholesterol in Patients With Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 10/8/2015
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Acute Microvascular Changes With LDL Apheresis
Status: Enrolling
Updated: 10/23/2015
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling,
Phase
II
Updated: 8/21/2015
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling,
Phase
II
Updated: 8/21/2015
Click here to add this to my saved trials
Homozygous Familial Hypercholesterolemia Clinical Trial
The Rogosin Institute Homozygous Familial Hypercholesterolemia Repository
Status: Enrolling
Updated: 2/8/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/7/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Evaluation of Lipoproteins
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy
Status: Enrolling
Updated: 3/11/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Primary Hyperlipidemia or Mixed Dyslipidemia At Risk Of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/23/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Perfusion Imaging With Myocardial Contrast Echocardiography in HCM
Status: Enrolling
Updated: 3/28/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy
Status: Enrolling,
Phase
II, III
Updated: 3/29/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects With Hyperlipidemia or Mixed Dyslipidemia at Risk of Cardiovascular Events
Status: Enrolling,
Phase
III
Updated: 3/10/2016
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Effects of Worksite Wellness Interventions on Vascular Function, Insulin Sensitivity and High-Density Lipoprotein in Overweight or Obese Women
Status: Enrolling
Updated: 3/20/2012
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
The Inhibition of Platelet Antiaggregating Activity of Clopidogrel by Atorvastatin Detected by Erythromycin Breath Test: a Metabolic Inhibition of Hepatic Cytochrome P450-3A
Status: Enrolling
Updated: 6/23/2005
Click here to add this to my saved trials
Hyperlipidemia Clinical Trial
Endothelial Hyperpolarization in Humans
Status: Enrolling,
Phase
II
Updated: 8/28/2014
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology Clinical Trial
Translating a Heart Disease Lifestyle Intervention Into the Community
Status: Enrolling
Updated: 4/15/2013
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Endocrinology, Pharmacology / Toxicology Clinical Trial
Effects of Almond Intake on Atherogenic Dyslipidemia of the Metabolic Syndrome
Status: Enrolling
Updated: 11/24/2015
Click here to add this to my saved trials
Cardiology / Vascular Diseases, Gastroenterology, Immunology / Infectious Diseases, Pharmacology / Toxicology Clinical Trial
Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease
Status: Enrolling
Updated: 3/3/2015
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Dyslipidemia Clinical Trial
Efficacy and Safety of PRC-4016 in Subjects With Mixed Dyslipidemia
Status: Enrolling,
Phase
II
Updated: 1/13/2014
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling,
Phase
II
Updated: 10/5/2015
Click here to add this to my saved trials
Hypertrophic Cardiomyopathy Clinical Trial
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Status: Enrolling,
Phase
II
Updated: 10/5/2015
Click here to add this to my saved trials
Hypertriglyceridemia Clinical Trial
Trial of ARI-3037MO to Reduce Triglyceride Levels in Adults With Severe (≥500 mg/dl) Hypertriglyceridemia
Status: Enrolling,
Phase
II
Updated: 8/21/2015
Click here to add this to my saved trials
Updated: 3/10/2016


Updated: 12/23/2015

Updated: 6/19/2013

Updated: 9/5/2014

Updated: 3/7/2011

Updated: 3/15/2013

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 10/5/2015

Updated: 10/8/2015

Updated: 10/23/2015

Updated: 8/21/2015

Updated: 8/21/2015

Updated: 2/8/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/7/2016

Updated: 3/11/2016

Updated: 3/11/2016

Updated: 3/11/2016

Updated: 3/11/2016

Updated: 3/11/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/23/2016

Updated: 3/28/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/29/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/10/2016

Updated: 3/20/2012

Updated: 6/23/2005

Updated: 8/28/2014

Updated: 4/15/2013

Updated: 11/24/2015

Updated: 3/3/2015

Updated: 1/13/2014

Updated: 1/13/2014

Updated: 10/5/2015

Updated: 10/5/2015

Updated: 8/21/2015
